Showing results (141-150 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|July 25, 2016
Melatonin and Human Cardiovascular DiseaseSeithikurippu R Pandi-Perumal, Ahmed S BaHammam, Nwakile I Ojike, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 19, 2020
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled TrialsSarah W Chiu, Cristina M Pratt, Richard Feinn, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 12, 2020
Hydrogen Sulfide Therapy Suppresses Cofilin-2 and Attenuates Ischemic Heart Failure in a Mouse Model of Myocardial InfarctionKhoa Nguyen, Vinh Q Chau, Adolfo G Mauro, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 2, 2015
β3-Adrenoceptor Impairs Mitochondrial Biogenesis and Energy Metabolism During Rapid Atrial Pacing-Induced Atrial FibrillationJingmei Dong, Jingjing Zhao, Miaomiao Zhang, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 2, 2015
The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion InjuryXi Shi, Margaret M O'Neill, Scott MacDonnell, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 27, 2015
Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled TrialsWei-jie Bei, Chong-yang Duan, Ji-yan Chen, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 3, 2015
Direct Vasodilators and Sympatholytic AgentsMeghan N McComb, James Y Chao, Tien M H NgJournal of Cardiovascular Pharmacology and Therapeutics|August 5, 2016
Increased Benefit With Vorapaxar Use in Patients With a History of Myocardial Infarction and Diabetes Mellitus: What the Data Show UsIraklis C Moschonas, Alexandros D TselepisJournal of Cardiovascular Pharmacology and Therapeutics|May 1, 2020
Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal DisorderHimanshu Sankrityayan, Ajinath Kale, Nisha Sharma, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanismsRobert J Henning, Yongxiang LiPageof 129